Resources Contact Us Home
Immunological composition of measles virus utilizing recombinant poxvirus

Image Number 18 for United States Patent #5759841.

What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.

  Recently Added Patents
System and method for configuring a direct lift control system of a vehicle
Mechanism for visible users and groups
Monitoring system
Build process management system
Charged particle cancer therapy beam path control method and apparatus
  Randomly Featured Patents
Tool holder
Multicolor printing press
Petunia plant named `Glow Lavender Shades`
Lock ring assembly and disassembly method
Adapter for shaped charge casing
Sewing machine
Circuit breaker
Decal removal composition
Method and apparatus for controlling shared memory and method of accessing shared memory
Device on rotary snow plough